Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push
An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.
Search fresh public links, source activity, and ready-to-use post angles for Biotech Startup.
Fresh curated links around biotech startup are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.
Several successful biotech startups trace their roots to BIRAC. Cleantech company GPS Renewables, for example, received funding under BIRAC’s Biotechnology Ignition Grant.
Prime Venture Partners and Leo Capital lead investment as the IIT Delhi-founded startup bets on precision fermentation and bio-manufacturing for global markets.
Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...
Led by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more following closely behind.
Biotech’s effervescent activity has allowed it to overcome headwinds and sustain momentum into 2026, as the volume and value of licensing and M&A deals continues to increase. N...
The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum that’s already yielded several big-ticket IPOs.
BOSTON, July 5, 2026 /PRNewswire/ -- Following its success building a solid foundation on the U.S. West Coast, Startup Island TAIWAN, a national brand backed by the National Develo...
The multipronged approach of Biotechnology Industry Research Assistance Council (BIRAC) encompassing funding, infrastructure, networks, market reach has led to expansion of biotech...
ChemT Biotechnology, a US‑Singapore startup that claims it has built an “intelligence layer” for bio-manufacturing, has raised a total of US$5 million in 18 months, including a US$...
The California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14th biotech to go public in 2026.
Historically, Indian pharmaceutical companies have focused on generics and services businesses, which carry lower risk and shorter development
Treeline Biosciences, an under-the-radar cancer company that has raised more than $1 billion since its 2021 founding, is looking to step into the spotlight of the public market. Tr...
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
Parabilis is teeing up the latest high-profile stock issuance in a year when biotech IPOs are averaging more than $286 million in total proceeds.
The Series B round was led by Battery Ventures.
Celea, backed by investors such as RA Capital and Leaps by Bayer, is making what it says is an improved version of Roche's Esbriet.
Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and why it happens. The post The Naming Patterns Behind 12,...
The first human patient has received a dose of Life Biosciences’ sight recovery drug.
The biotechnology startup emerged from stealth with a peptide drug it claims to have the potential to reverse lung scarring in people with idiopathic pulmonary fibrosis.
Fragrance tech company Patina announced Thursday a $2 million raise from investors, including Betaworks and True Ventures.
The largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now resulted in 12 drug startups securing more than $4.1 billion...
Merck KGaA has committed $50 million to build a new biotech with prolific life science investor Versant Ventures, with the ultimate goal of devouring the NewCo down the line.
As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.